Serotonin receptor diversity in the human colon: Expression of serotonin type 3 receptor subunits 5-HT3C, 5-HT3D, and 5-HT3E

Journal of Comparative Neurology

Volumn 519, Issue 3, 2011, Pages 420-432

  Kapeller, Johannes ^a   Möller, Dorothee ^a   Lasitschka, Felix ^a   Autschbach, Frank ^a   Hovius, Ruud ^b   Rappold, Gudrun ^a   Brüss, Michael ^c   Gershon, Michael D ^d   Niesler, Beate ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b EPFL   (Switzerland)

^c UNIVERSITY OF BONN   (Germany)

^d NewYork Presbyterian Hospital   (United States)

Author keywords

5 HT receptor; 5 HT3; Antibody; Gastrointestinal tract; Ligand gated ion channel

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CD45 ANTIGEN; CYTOKERATIN 20; SEROTONIN 3 RECEPTOR; SEROTONIN 3A RECEPTOR; SEROTONIN 3C RECEPTOR; SEROTONIN 3D RECEPTOR; SEROTONIN 3E RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; CENTRAL NERVOUS SYSTEM; COLON; DIVERTICULITIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE TEST; IMMUNOREACTIVITY; INTESTINE INNERVATION; LAMINA PROPRIA; LASER MICRODISSECTION; MALE; MYENTERIC PLEXUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AGED; CELL LINE; COLON; FEMALE; HUMANS; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; PROTEIN SUBUNITS; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 78650637997     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.22525     Document Type: Article

References (63)

1. Barnes NM, Hales TG, Lummis SC, Peters JA. 2009. The 5-HT3 receptor-the relationship between structure and function. Neuropharmacology 56: 273-284.
2. Bearcroft CP, Andre EA, Farthing MJ. 1997. In vivo effects of the 5-HT3 antagonist alosetron on basal and cholera toxin-induced secretion in the human jejunum: a segmental perfusion study. Aliment Pharmacol Ther 11: 1109-1114.
3. Belelli D, Balcarek JM, Hope AG, Peters JA, Lambert JJ, Blackburn TP. 1995. Cloning and functional expression of a human 5-hydroxytryptamine type 3AS receptor subunit. Mol Pharmacol 48: 1054-1062.
4. Bertrand PP, Kunze WAA, Bornstein JC, Furness JB, Smith ML. 1997. Analysis of the responses of myenteric neurons in the small intestine to chemical stimulation of the mucosa. Am J Physiol 36: G422-G435.
5. Bottner M, Bar F, Von Koschitzky H, Tafazzoli K, Roblick UJ, Bruch HP, Wedel T. 2009. Laser microdissection as a new tool to investigate site-specific gene expression in enteric ganglia of the human intestine. Neurogastroenterol Motil 22: 168-172, e152.
6. Boyd GW, Low P, Dunlop JI, Robertson LA, Vardy A, Lambert JJ, Peters JA, Connolly CN. 2002. Assembly and cell surface expression of homomeric and heteromeric 5-HT3 receptors: the role of oligomerization and chaperone proteins. Mol Cell Neurosci 21: 38-50.
7. Camilleri M, Kerstens R, Rykx A, Vandeplassche L. 2008. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med 358: 2344-2354.
8. Chameau P, van Hooft JA. 2006. Serotonin 5-HT3 receptors in the central nervous system. Cell Tissue Res 326: 573-581.
9. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
10. Davies PA, Pistis M, Hanna MC, Peters JA, Lambert JJ, Hales TG, Kirkness EF. 1999. The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature 397: 359-363.
11. Day J, King B, Haque SM, Kellum JM. 2005. A nonneuronal 5-hydroxytryptamine receptor 3 induces chloride secretion in the rat distal colonic mucosa. Am J Surg 190: 736-738.
12. Engelmann BE, Bindslev N, Poulsen SS, Larsen R, Hansen MB. 2006. Functional characterization of serotonin receptor subtypes in human duodenal secretion. Basic Clin Pharmacol Toxicol 98: 142-149.
13. Fiebich BL, Akundi RS, Seidel M, Geyer V, Haus U, Muller W, Stratz T, Candelario-Jalil E. 2004. Expression of 5-HT3A receptors in cells of the immune system. Scand J Rheumatol Suppl 119: 9-11.
14. Fletcher S, Barnes NM. 1998. Desperately seeking subunits: are native 5-HT3 receptors really homomeric complexes? Trends Pharmacol Sci 19: 212-215.
15. Gaddum JH, Picarelli ZP. 1957. Two kinds of tryptamine receptor. Br J Pharmacol Chemother 12: 323-328.
16. Galligan JJ. 1996. Electrophysiological studies of 5-hydroxytryptamine receptors on enteric neurons. Behav Brain Res 73: 199-201.
17. Gershon MD. 2003. Serotonin and its implication for the management of irritable bowel syndrome. Rev Gastroenterol Disord 3( Suppl 2): S25-S34.
18. Gershon MD. 2004. Review article: serotonin receptors and transporters-roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther 20( Suppl 7): 3-14.
19. Gershon MD. 2005. Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome. J Clin Gastroenterol 39( Suppl 5): S184-S193.
20. Gershon MD, Tack J. 2007. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132: 397-414.
21. Gill RK, Pant N, Saksena S, Singla A, Nazir TM, Vohwinkel L, Turner JR, Goldstein J, Alrefai WA, Dudeja PK. 2008. Function, expression, and characterization of the serotonin transporter in the native human intestine. Am J Physiol Gastrointest Liver Physiol 294: G254-G262.
22. Graeff FG. 1997. Serotonergic systems. Psychiatr Clin North Am 20: 723-739.
23. Grider JR. 2003. Neurotransmitters mediating the intestinal peristaltic reflex in the mouse. J Pharmacol Exp Ther 307: 460-467.
24. Grundy D, Schemann M. 2006. Enteric nervous system. Curr Opin Gastroenterol 22: 102-110.
25. Hoff S, Zeller F, von Weyhern CW, Wegner M, Schemann M, Michel K, Ruhl A. 2008. Quantitative assessment of glial cells in the human and guinea pig enteric nervous system with an anti-Sox8/9/10 antibody. J Comp Neurol 509: 356-371.
26. Holbrook JD, Gill CH, Zebda N, Spencer JP, Leyland R, Rance KH, Trinh H, Balmer G, Kelly FM, Yusaf SP, Courtenay N, Luck J, Rhodes A, Modha S, Moore SE, Sanger GJ, Gunthorpe MJ. 2009. Characterisation of 5-HT3C, 5-HT3D and 5-HT3E receptor subunits: evolution, distribution and function. J Neurochem 108: 384-396.
27. Humphrey PP, Bountra C, Clayton N, Kozlowski K. 1999. Review article: the therapeutic potential of 5-HT3 receptor antagonists in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 13( Suppl 2): 31-38.
28. Hussy N, Lukas W, Jones KA. 1994. Functional properties of a cloned 5-hydroxytryptamine ionotropic receptor subunit: comparison with native mouse receptors. J Physiol 481: 311-323.
29. Jackson MB, Yakel JL. 1995. The 5-HT3 receptor channel. Annu Rev Physiol 57: 447-468.
30. Johnson DS, Heinemann SF. 1995. Detection of 5-HT3R-A, a 5-HT3 receptor subunit, in submucosal and myenteric ganglia of rat small intestine using in situ hybridization. Neurosci Lett 184: 67-70.
31. Jones BJ, Blackburn TP. 2002. The medical benefit of 5-HT research. Pharmacol Biochem Behav 71: 555-568.
32. Kapeller J, Houghton LA, Monnikes H, Walstab J, Moller D, Bonisch H, Burwinkel B, Autschbach F, Funke B, Lasitschka F, Gassler N, Fischer C, Whorwell PJ, Atkinson W, Fell C, Buchner KJ, Schmidtmann M, van der Voort I, Wisser AS, Berg T, Rappold G, Niesler B. 2008. First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome. Hum Mol Genet 17: 2967-2977.
33. Karaus M, Sarna SK. 1987. Giant migrating contractions during defecation in the dog colon. Gastroenterology 92: 925-933.
34. Karnovsky AM, Gotow LF, McKinley DD, Piechan JL, Ruble CL, Mills CJ, Schellin KA, Slightom JL, Fitzgerald LR, Benjamin CW, Roberds SL. 2003. A cluster of novel serotonin receptor 3-like genes on human chromosome 3. Gene 319: 137-148.
35. Krimm RF, Davis BM, Noel T, Albers KM. 2006. Overexpression of neurotrophin 4 in skin enhances myelinated sensory endings but does not influence sensory neuron number. J Comp Neurol 498: 455-465.
36. Lee JH, Koh H, Kim M, Kim Y, Lee SY, Karess RE, Lee SH, Shong M, Kim JM, Kim J, Chung J. 2007. Energy-dependent regulation of cell structure by AMP-activated protein kinase. Nature 447: 1017-1020.
37. Lennerz JK, Ruhle V, Ceppa EP, Neuhuber WL, Bunnett NW, Grady EF, Messlinger K. 2008. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 507: 1277-1299.
38. Lin Z, Gao N, Hu HZ, Liu S, Gao C, Kim G, Ren J, Xia Y, Peck OC, Wood JD. 2002. Immunoreactivity of Hu proteins facilitates identification of myenteric neurones in guinea-pig small intestine. Neurogastroenterol Motil 14: 197-204.
39. Liu MT, Rayport S, Jiang Y, Murphy DL, Gershon MD. 2002. Expression and function of 5-HT3 receptors in the enteric neurons of mice lacking the serotonin transporter. Am J Physiol Gastrointest Liver Physiol 283: G1398-G1411.
40. Liu M, Geddis MS, Wen Y, Setlik W, Gershon MD. 2005. Expression and function of 5-HT4 receptors in the mouse enteric nervous system. Am J Physiol Gastrointest Liver Physiol 289: G1148-G1163.
41. Liu MT, Kuan YH, Wang J, Hen R, Gershon MD. 2009. 5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice. J Neurosci 29: 9683-9699.
42. Marusich MF, Furneaux HM, Henion PD, Weston JA. 1994. Hu neuronal proteins are expressed in proliferating neurogenic cells. J Neurobiol 25: 143-155.
43. Mawe GM, Branchek TA, Gershon MD. 1986. Peripheral neural serotonin receptors: identification and characterization with specific antagonists and agonists. Proc Natl Acad Sci U S A 83: 9799-9803.
44. Michel K, Zeller F, Langer R, Nekarda H, Kruger D, Dover TJ, Brady CA, Barnes NM, Schemann M. 2005. Serotonin excites neurons in the human submucous plexus via 5-HT3 receptors. Gastroenterology 128: 1317-1326.
45. Miyake A, Mochizuki S, Takemoto Y, Akuzawa S. 1995. Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species. Mol Pharmacol 48: 407-416.
46. Muller-Lissner SA, Fumagalli I, Bardhan KD, Pace F, Pecher E, Nault B, Ruegg P. 2001. Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 15: 1655-1666.
47. Murphy EM, Defontgalland D, Costa M, Brookes SJ, Wattchow DA. 2007. Quantification of subclasses of human colonic myenteric neurons by immunoreactivity to Hu, choline acetyltransferase and nitric oxide synthase. Neurogastroenterol Motil 19: 126-134.
48. Nagakura Y, Kiso T, Miyata K, Ito H, Iwaoka K, Yamaguchi T. 2002. The effect of the selective 5-HT3 receptor agonist on ferret gut motility. Life Sci 71: 1313-1319.
49. Niesler B, Frank B, Kapeller J, Rappold GA. 2003. Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E. Gene 310: 101-111.
50. Niesler B, Walstab J, Combrink S, Moller D, Kapeller J, Rietdorf J, Bonisch H, Gothert M, Rappold G, Bruss M. 2007. Characterization of the novel human serotonin receptor subunits 5-HT3C, 5-HT3D, and 5-HT3E. Mol Pharmacol 72: 8-17.
51. 1A and 5-HT4 receptors mediate inhibition and facilitation of fast synaptic transmission in enteric neurons. Am J Physiol 266: G230-G238.
52. Pan H, Gershon MD. 2000. Activation of intrinsic afferent pathways in submucosal ganglia of the guinea pig small intestine. J Neurosci 20: 3295-3309.
53. Peters JA, Lummis SCR, Barnes NM, Hales TG, Niesler B. 2010. 5-HT3 receptors. IUPHAR database (IUPHAR-DB).
54. Ren J, Zhou X, Galligan JJ. 2008. 5-HT4 receptor activation facilitates recovery from synaptic rundown and increases transmitter release from single varicosities of myenteric neurons. Am J Physiol Gastrointest Liver Physiol 294: G1376-G1383.
55. Sakurai-Yamashita Y, Yamashita K, Yoshimura M, Taniyama K. 2000. Differential localization of 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptors in the human rectum. Life Sci 66: 31-34.
56. Sams VR, Bobrow LG, Happerfield L, Keeling J. 1992. Evaluation of PGP9.5 in the diagnosis of Hirschsprung's disease. J Pathol 168: 55-58.
57. Sarna SK. 2007. Enteric descending and afferent neural signaling stimulated by giant migrating contractions: essential contributing factors to visceral pain. Am J Physiol Gastrointest Liver Physiol 292: G572-G581.
58. Simpson J, Sundler F, Humes DJ, Jenkins D, Scholefield JH, Spiller RC. 2009. Post inflammatory damage to the enteric nervous system in diverticular disease and its relationship to symptoms. Neurogastroenterol Motil 21: e847-e858.
59. Tack JF, Janssens J, Vantrappen G, Wood JD. 1992. Actions of 5-hydroxytryptamine on myenteric neurons in guinea pig gastric antrum. Am J Physiol 263: G838-G846.
60. Thompson AJ, Lummis SC. 2007. The 5-HT3 receptor as a therapeutic target. Expert Opin Ther Targets 11: 527-540.
61. Wade PR, Tamir H, Kirchgessner AL, Gershon MD. 1994. Analysis of the role of 5-HT in the enteric nervous system using anti-idiotopic antibodies to 5-HT receptors. Am J Physiol 266: G403-G416.
62. Walstab J, -Hammer C, Lasitschka F, Moeller D, Connolly CN, Rappold G, Bruss M, Bonisch H, Niesler B. 2010a. RIC-3 exclusively enhances the surface expression of human homomeric 5-hydroxytryptamine type 3A (5-HT3A) receptors, despite direct interactions with 5-HT3A, C, D and E subunits. J Biol Chem 285: 26956-26965.
63. Walstab J, Rappold G, Niesler B. 2010b. 5-HT3 receptors: role in disease and target of drugs. Pharmacol Ther 128: 146-169.